The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(2-Methyl-5-nitro-1H-imidazol-1-yl)ethyl 3,5-dimethoxybenzoate ID: ALA4086122
Cas Number: 941010-49-7
PubChem CID: 16645447
Max Phase: Preclinical
Molecular Formula: C15H17N3O6
Molecular Weight: 335.32
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COc1cc(OC)cc(C(=O)OCCn2c([N+](=O)[O-])cnc2C)c1
Standard InChI: InChI=1S/C15H17N3O6/c1-10-16-9-14(18(20)21)17(10)4-5-24-15(19)11-6-12(22-2)8-13(7-11)23-3/h6-9H,4-5H2,1-3H3
Standard InChI Key: QRFXPTOQJWCHTI-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 25 0 0 0 0 0 0 0 0999 V2000
19.0213 -2.0885 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.6758 -1.5992 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.4144 -0.8248 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5947 -0.8356 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.3558 -1.6162 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0314 -2.9056 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4582 -1.8417 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.0586 -1.2874 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.6381 -2.6389 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.7441 -3.3054 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7542 -4.1225 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.4670 -4.5223 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4771 -5.3395 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.1696 -4.1050 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.5823 -1.8797 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7737 -5.7518 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7835 -6.5682 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4968 -6.9688 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2017 -6.5471 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.1884 -5.7321 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0807 -6.9852 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.3682 -6.5851 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.9158 -6.9443 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22.6169 -6.5245 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 2 0
5 1 1 0
1 6 1 0
7 8 2 0
7 9 1 0
2 7 1 0
6 10 1 0
10 11 1 0
11 12 1 0
12 13 1 0
12 14 2 0
5 15 1 0
13 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 13 1 0
17 21 1 0
21 22 1 0
19 23 1 0
23 24 1 0
M CHG 2 7 1 9 -1
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 335.32Molecular Weight (Monoisotopic): 335.1117AlogP: 1.97#Rotatable Bonds: 7Polar Surface Area: 105.72Molecular Species: NEUTRALHBA: 8HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 9HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 3.27CX LogP: 1.72CX LogD: 1.72Aromatic Rings: 2Heavy Atoms: 24QED Weighted: 0.43Np Likeness Score: -1.22
References 1. Salar U, Khan KM, Taha M, Ismail NH, Ali B, Qurat-Ul-Ain, Perveen S, Ghufran M, Wadood A.. (2017) Biology-oriented drug synthesis (BIODS): In vitro β-glucuronidase inhibitory and in silico studies on 2-(2-methyl-5-nitro-1H-imidazol-1-yl)ethyl aryl carboxylate derivatives., 125 [PMID:27886546 ] [10.1016/j.ejmech.2016.11.031 ]